• 24
  • 8
  • Favorite

复星医药AH齐涨,传新冠疫苗通过专家评审

老虎资讯综合2021-07-15

7月15日,复星医药港股盘初大涨涨近7%,报61.3港元;复星医药A股涨逾5%,报68.17元。

据财新,复星医药在股东大会上回复投资人问询时表示,国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成,专家评审已经通过了,目前正在加紧进行行政审批阶段。

复星医药已与BioNTech提前启动生产准备工作,复必泰疫苗一旦获批,就能第一时间供应到国内;知情人士称,未来,复必泰在国内很可能会作为加强针使用,免费接种。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment8

  • 難道不打國產的不讓打?
    Reply
    Report
  • 圆润的石头
    ·2021-07-15
    可以和滅活疫苗混打?
    Reply
    Report
  • Jamesong
    ·2021-07-15
    爲什麼不早批准?
    Reply
    Report
  • Jet2017
    ·2021-07-15
    都在等着呢
    Reply
    Report
  • 說好的利好出盡呢
    Reply
    Report
  • 求金
    ·2021-07-15
    [暗中觀察] 
    Reply
    Report
    Fold Replies
    • 求金
      [强]
      2021-07-15
      Reply
      Report
  • 股海摩西
    ·2021-07-15
    Zan
    Reply
    Report
    Fold Replies
  • 麦基Zzzz
    ·2021-07-15
    加強針?不是混打嗎?
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial